Universität zu Köln

Venhuizen, Freerk G., van Ginneken, Bram ORCID: 0000-0003-2028-8972, van Asten, Freekje ORCID: 0000-0002-8141-4234, van Grinsven, Mark J. J. P., Fauser, Sascha, Hoyng, Carel B., Theelen, Thomas and Sanchez, Clara I. (2017). Automated Staging of Age-Related Macular Degeneration Using Optical Coherence Tomography. Invest. Ophthalmol. Vis. Sci., 58 (4). S. 2318 - 2329. ROCKVILLE: ASSOC RESEARCH VISION OPHTHALMOLOGY INC. ISSN 1552-5783

Riaz, Moeen, Lores-Motta, Laura ORCID: 0000-0002-2423-9126, Richardson, Andrea J., Lu, Yi ORCID: 0000-0001-9933-3654, Montgomery, Grant, Omar, Amer ORCID: 0000-0003-1520-392X, Koenekoop, Robert K., Chen, John, Muether, Philipp, Altay, Lebriz, Schick, Tina, Fauser, Sascha, Smailhodzic, Dzenita, van Asten, Freekje ORCID: 0000-0002-8141-4234, de Jong, Eiko K., Hoyng, Carel B., Burdon, Kathryn P., MacGregor, Stuart, Guymer, Robyn H., den Hollander, Anneke I. and Baird, Paul N. (2016). GWAS study using DNA pooling strategy identifies association of variant rs4910623 in OR52B4 gene with anti-VEGF treatment response in age-related macular degeneration. Sci Rep, 6. LONDON: NATURE PUBLISHING GROUP. ISSN 2045-2322

Lores-Motta, Laura ORCID: 0000-0002-2423-9126, van Asten, Freekje ORCID: 0000-0002-8141-4234, Muether, Philipp S., Smailhodzic, Dzenita, Groenewoud, Joannes M., Omar, Amer ORCID: 0000-0003-1520-392X, Chen, John, Koenekoop, Robert K., Fauser, Sascha, Hoyng, Carel B., den Hollander, Anneke I. and de Jong, Eiko K. (2016). A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration. Pharmacogenet. Genomics, 26 (1). S. 20 - 28. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1744-6880

Hermann, Manuel M., van Asten, Freekje ORCID: 0000-0002-8141-4234, Muether, Philipp S., Smailhodzic, Dzenita, Lichtner, Peter, Hoyng, Carel B., Kirchhof, Bernd, Grefkes, Christian ORCID: 0000-0002-1656-720X, den Hollander, Anneke I. and Fauser, Sascha (2014). Polymorphisms in Vascular Endothelial Growth Factor Receptor 2 Are Associated with Better Response Rates to Ranibizumab Treatment in Age-related Macular Degeneration. Ophthalmology, 121 (4). S. 905 - 911. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1549-4713

van Asten, Freekje ORCID: 0000-0002-8141-4234, Rovers, Maroeska M., Lechanteur, Yara T. E., Smailhodzic, Dzenita, Muether, Philipp S., Chen, John, den Hollander, Anneke I., Fauser, Sascha, Hoyng, Carel B., van der Wilt, Gert Jan ORCID: 0000-0002-5856-762X and Klevering, B. Jeroen (2014). Predicting Non-response to Ranibizumab in Patients with Neovascular Age-related Macular Degeneration. Ophthalmic Epidemiol., 21 (6). S. 347 - 356. PHILADELPHIA: TAYLOR & FRANCIS INC. ISSN 1744-5086

Smailhodzic, Dzenita, van Asten, Freekje ORCID: 0000-0002-8141-4234, Blom, Anna M., Mohlin, Frida C., den Hollander, Anneke I., van de Ven, Johannes P. H., van Huet, Ramon A. C., Groenewoud, Joannes M. M., Tian, Yuan, Berendschot, Tos T. J. M., Lechanteur, Yara T. E., Fauser, Sascha, de Bruijn, Chris, Daha, Mohamed R., van der Wilt, Gert Jan, Hoyng, Carel B. and Klevering, B. Jeroen (2014). Zinc Supplementation Inhibits Complement Activation in Age-Related Macular Degeneration. PLoS One, 9 (11). SAN FRANCISCO: PUBLIC LIBRARY SCIENCE. ISSN 1932-6203